SAFETY AND EFFICACY OF 10mg (HIGH-DOSE) BULEVIRTIDE (MYRCLUDEX B) IN COMBINATION WITH PEG-INTERFERON ALPHA 2a OR TENOFOVIR IN PATIENTS WITH CHRONIC HBV/HDV CO-INFECTION: WEEK 24 INTERIM RESULTS OF THE MYR203 EXTENSION STUDY.

被引：0

作者：

Wedemeyer, Heiner ^{[1
]}

Schoeneweis, Katrin ^{[2
]}

Bogomolov, Pavel ^{[3
]}

Voronkova, Natalia ^{[4
]}

Chulanov, Vladimir

Stepanova, Tatyana ^{[5
]}

Allweiss, Lena ^{[6
,7
]}

Dandri, Maura ^{[8
,9
]}

Ciesek, Sandra ^{[10
]}

Dittmer, Ulf ^{[11
]}

Haefeli, Walter E. ^{[12
]}

Alexandrov, Alexander ^{[13
]}

Urban, Stephan ^{[14
]}

机构：

[1] Univ Duisburg Essen, Dept Gastroenterol & Hepatol, Essen Univ Hosp, Duisburg, Germany

[2] Myr Gmbh, Burgwedel, Germany

[3] MF Vladimirskiy Moscow Reg Res Clin Inst, Hepatol, Moscow, Russia

[4] Moscow Reg Sci Res, Hepatol Dept, Inst Clin, Moscow, Russia

[5] Modern Med Clin, Moscow, Russia

[6] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med 1, Hamburg, Germany

[7] German Ctr Infect Res DZIF Hamburg Lubeck Borstel, Munich, Germany

[8] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany

[9] Germany German Ctr Infect Res DZIF, Munich, Germany

[10] Univ Klinikum Frankfurt, Inst Med Virol, Frankfurt, Germany

[11] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Duisburg, Germany

[12] German Ctr Infect Res DZIF, Heidelberg Partner Site, Heidelberg, Germany

[13] Myr Gmbh, Bad Homburg, Germany

[14] Univ Hosp Heidelberg, Mol Virol, Dept Infect Dis, Heidelberg, Germany

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：58A / 59A

页数：2

共 5 条

[1] Interim Results of a Multicentre, Open-Label Phase 2 Clinical Trial (MYR203) to Assess Safety and Efficacy of Myrcludex B in Combination with Peg-Interferon Alpha 2a in Patients with Chronic HBV/Hdv Co-Infection
Wedemeyer, Heiner
Schoeneweis, Katrin
Bogomolov, Pavel O.
Voronkova, Natalia V.
Chulanov, Vladimir
Stepanova, Tatyana
Bremer, Birgit
Lehmann, Patrick
Raupach, Regina
Alleiss, Lena
Dandri, Maura
Ciesek, Sandra
Dittmer, Ulf
Haefeli, Walter E.
Alexandrov, Alexander
Urban, Stephan
HEPATOLOGY, 2018, 68 : 11A - 11A
[2] Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection
Wedemeyer, Heiner
Schoeneweis, Katrin
Bogomolov, Pavel O.
Voronkova, Natalia
Chulanov, Vladimir
Stepanova, Tatyana
Bremer, Birgit
Allweiss, Lena
Dandri, Maura
Burhenne, Juergen
Haefeli, Walter-Emil
Ciesek, Sandra
Dittmer, Ulf
Alexandrov, Alexander
Urban, Stephan
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E81 - E81
[3] Interim results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
Wedemeyer, Heiner
Alexandrov, Alexander
Bogomolov, Pavel
Blank, Antje
Bremer, Birgit
Voronkova, Natalia
Schoneweis, Katrin
Raupach, Regina
Lehmann, Patrick
Darnedde, Martina
Pathil, Anita
Burhenne, Jurgen
Haag, Mathias
Schwab, Matthias
Haefeli, Walter E.
Urban, Stephan
HEPATOLOGY, 2017, 66 : 20A - 21A
[4] Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
Wedemeyer, H.
Bogomolov, P.
Blank, A.
Allweiss, L.
Dandri-Petersen, M.
Bremer, B.
Voronkova, N.
Schoeneweis, K.
Pathil, A.
Burhenne, J.
Haag, M.
Schwab, M.
Haefeli, W. -E.
Wiesch, J. S. Z.
Alexandrov, A.
Urban, S.
JOURNAL OF HEPATOLOGY, 2018, 68 : S3 - S3
[5] EFFICACY AND SAFETY OF siRNA JNJ-73763989, CAPSID ASSEMBLY MODULATOR- E (CAM-E) JNJ - 56136379, AND NUCLEOS(T) IDE ANALOGS ( NA) WITH PEGYLATED INTERFERON ALPHA-2a (PEGIFN-α2a) ADDED IN IMMUNE - TOLERANT PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION: INTERIM RESULTS FROM THE PHASE 2 REEF- IT STUDY
Kennedy, Patrick T.
Fung, Scott K.
Buti, Maria
Yilmaz, Gurdal
Chuang, Wan Long
Asselah, Tarik
Kurosaki, Masayuki
Jezorwski, John
Verbinnen, Thierry
Kakuda, Thomas N.
Lenz, Oliver
Guinard-Azadian, Carine
Biermer, Michal
HEPATOLOGY, 2023, 78 : S568 - S570

← 1 →